Does Triamcinolone Acetonide Extended Release Injectable Suspensi Interact with Acidifying Agents?
CDI records a moderate classification for Triamcinolone Acetonide Extended Release Injectable Suspensi and Acidifying Agents. The stored summary is: Corticosteroids may increase blood glucose concentrations; dosage adjustments of antidiabetic agents may be required. The mechanism involves hyperglycemic effect of corticosteroids. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Hyperglycemic effect of corticosteroids
What To Tell Your Doctor or Pharmacist
If you are taking Triamcinolone Acetonide Extended Release Injectable Suspensi and your doctor is considering prescribing Acidifying Agents (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider